After SII s Covishield, Bharat Biotech plans to put its COVID-19 vaccine for approval before expert panel
After SII s Covishield, Bharat Biotech plans to put its COVID-19 vaccine for approval before expert panel
IANSDec 30, 2020, 17:30 IST
BCCL
Bharat Biotech will make a presentation before the
Subject Expert Committee of the Central Drug Standard Control Organisation (CDSCO) on Wednesday evening for approval of its
vaccine - Covaxin, government sources.
Earlier on Wednesday, the
Serum Institute of India (SII) s application for emergency use authorisation of its Covid-19 vaccine was also considered by the Subject Expert Committee. The development came hours after the United Kingdom accepted the recommendation of the Medicines and Healthcare Regulatory Agency (MHRA) to authorise the Oxford University-AstraZeneca s Covid-19 vaccine,
Bharat Biotech to make presentation before expert panel for vaccine approval
By IANS |
Published on
Wed, Dec 30 2020 17:27 IST |
0 Views
Bharat Biotech to make presentation before expert panel for vaccine approval. Image Source: IANS News
New Delhi, Dec 30 : Hyderabad-based Bharat Biotech will make a presentation before the Subject Expert Committee of the Central Drug Standard Control Organisation (CDSCO) on Wednesday evening for approval of its vaccine - Covaxin, government sources told IANS.
Earlier on Wednesday, the Serum Institute of India (SII) s application for emergency use authorisation of its Covid-19 vaccine was also considered by the Subject Expert Committee.
The development came hours after the United Kingdom accepted the recommendation of the Medicines and Healthcare Regulatory Agency (MHRA) to authorise the Oxford University-AstraZeneca s Covid-19 vaccine, Covishield, for emergency approval use.
The Subject Expert Committee of the Central Drug Standard Control Organization (CDSCO) is set to meet anytime Wednesday to consider the application of Serum Institute of India s for emergency use authorization of its Covid-19 vaccine, a senior government official said. The development came after the UK became the first country in the world to approve a coronavirus vaccine developed by Oxford University and AstraZeneca, even as it battled the new highly contagious variant of the coronavirus. The expert panel will consider the application of Adar Poonawalla s Pune firm, which has partnered with Oxford University and AstraZeneca to make the vaccine, for the emergency use authorization.